Minaris Advanced Therapies Capacity Update July 2025: Cell & Gene Therapy

Minaris Advanced Therapies is a global CDMO focused exclusively on cell and gene therapies, offering end-to-end support from development to commercial manufacturing and testing. With a robust track record of more than 7,500 GMP batches, proven platforms for multiple modalities, and sites across the U.S., Europe, and Asia, Minaris delivers speed, scalability, and reliability to help therapeutic developers bring cures to patients faster.